Please login to the form below

Not currently logged in
Email:
Password:

Abivax

This page shows the latest Abivax news and features for those working in and with pharma, biotech and healthcare.

Abivax enrols first patient in global phase 3 programme with obefazimod in ulcerative colitis

Abivax enrols first patient in global phase 3 programme with obefazimod in ulcerative colitis

Abivax has enrolled the first patients in its global phase 3 clinical programme, ABTECT, with obefazimod for the treatment of moderate to severe ulcerative colitis (UC), the company announced. ... reported. Abivax outlined that 1, 200 UC patients will

Latest news

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...